Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons-Reference-Cited by-同舟云学术

Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons

Published:2015-12-14 Issue:12 Volume:10 Page:e0144848
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Aguirre Pabla,Mena Natalia P.,Carrasco Carlos M.,Muñoz Yorka,Pérez-Henríquez Patricio,Morales Rodrigo A.,Cassels Bruce K.,Méndez-Gálvez Carolina,García-Beltrán Olimpo,González-Billault Christian,Núñez Marco T.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference51 articles.

1. Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration;HH Andersen;Cell Mol Life Sci,2013

2. The neuropathology of neurodegeneration with brain iron accumulation;MC Kruer;Int Rev Neurobiol,2013

3. Altered brain metabolism of iron as a cause of neurodegenerative diseases?;M Gerlach;J Neurochem,1994

4. Pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN): review of two major neurodegeneration with brain iron accumulation (NBIA) phenotypes;MA Kurian;Int Rev Neurobiol,2013

5. Excess iron harms the brain: the syndromes of neurodegeneration with brain iron accumulation (NBIA);SA Schneider;J Neural Transm,2013

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amphetamine-like Deferiprone and Clioquinol Derivatives as Iron Chelating Agents;Molecules;2024-09-05

2. On the Role of Iron in Idiopathic Parkinson’s Disease;Biomedicines;2023-11-20

3. The role of voltage-gated calcium channels in the pathogenesis of Parkinson’s disease;International Journal of Neuroscience;2022-11-07

4. Protective Effects of Maprotiline in 6-Hydroxydopamine (6-OHDA)-Induced Ferroptosis in Neuronal Cells;Journal of Biomedical Nanotechnology;2022-11-01

5. ATH434 Rescues Pre-motor Hyposmia in a Mouse Model of Parkinsonism;Neurotherapeutics;2022-09-29